Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Journal of Clinical Microbiology
|
December 1, 1994
Optimization of quantitative culture assay for human immunodeficiency virus from plasma. Plasma Viremia Group Laboratories of the AIDS Clinical Trials Group (National Institute of Allergy and Infectious Diseases)
J L Lathey, S A Fiscus, S Rasheed, et al.
Journal of Clinical Microbiology
|
June 2, 2000
Multicenter evaluation of methods to quantitate human immunodeficiency virus type 1 RNA in seminal plasma
S A Fiscus, D Brambilla, R W Coombs, et al.
The Journal of Infectious Diseases
|
February 1, 1995
Human immunodeficiency virus type 1 quantitative cell microculture as a measure of antiviral efficacy in a multicenter clinical trial
S A Fiscus, V DeGruttola, P Gupta, et al.
Antimicrobial Agents and Chemotherapy
|
September 16, 1998
Rapid ganciclovir susceptibility assay using flow cytometry for human cytomegalovirus clinical isolates
J J McSharry, N S Lurain, G L Drusano, et al.
The Journal of Infectious Diseases
|
May 1, 1995
Prevalence and clinical significance of zidovudine resistance mutations in human immunodeficiency virus isolated from patients after long-term zidovudine treatment. AIDS Clinical Trials Group 116B/117 Study Team and the Virology Committee Resistance Working Group
A J Japour, S Welles, R T D'Aquila, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 1993
Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates. The RV-43 Study Group, the AIDS Clinical Trials Group Virology Committee Resistance Working Group
A J Japour, D L Mayers, V A Johnson, et al.
Journal of Leukocyte Biology
|
September 14, 2000
Co-receptor usage was more predictive than NSI/SI phenotype for HIV replication in macrophages: is NSI/SI phenotyping sufficient?
J L Lathey, D Brambilla, M M Goodenow, et al.
AIDS (London, England)
|
August 16, 2001
A menstrual cycle pattern for cytokine levels exists in HIV-positive women: implication for HIV vaginal and plasma shedding
L Al-Harthi, A Kovacs, R W Coombs, et al.
The Journal of Infectious Diseases
|
October 13, 2001
Variation of human immunodeficiency virus type 1 viral RNA levels in the female genital tract: implications for applying measurements to individual women
R W Coombs, D J Wright, P S Reichelderfer, et al.
Journal of Clinical Microbiology
|
September 1, 1996
Evaluation of an infectivity standard for real-time quality control of human immunodeficiency virus type 1 quantitative micrococulture assays. Participating Laboratories of The AIDS Clinical Trials Group
W A Scott, D Brambilla, E Siwak, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Journal of Clinical Microbiology
|
December 1, 1994
Optimization of quantitative culture assay for human immunodeficiency virus from plasma. Plasma Viremia Group Laboratories of the AIDS Clinical Trials Group (National Institute of Allergy and Infectious Diseases)
J L Lathey, S A Fiscus, S Rasheed, et al.
Journal of Clinical Microbiology
|
June 2, 2000
Multicenter evaluation of methods to quantitate human immunodeficiency virus type 1 RNA in seminal plasma
S A Fiscus, D Brambilla, R W Coombs, et al.
The Journal of Infectious Diseases
|
February 1, 1995
Human immunodeficiency virus type 1 quantitative cell microculture as a measure of antiviral efficacy in a multicenter clinical trial
S A Fiscus, V DeGruttola, P Gupta, et al.
Antimicrobial Agents and Chemotherapy
|
September 16, 1998
Rapid ganciclovir susceptibility assay using flow cytometry for human cytomegalovirus clinical isolates
J J McSharry, N S Lurain, G L Drusano, et al.
The Journal of Infectious Diseases
|
May 1, 1995
Prevalence and clinical significance of zidovudine resistance mutations in human immunodeficiency virus isolated from patients after long-term zidovudine treatment. AIDS Clinical Trials Group 116B/117 Study Team and the Virology Committee Resistance Working Group
A J Japour, S Welles, R T D'Aquila, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 1993
Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates. The RV-43 Study Group, the AIDS Clinical Trials Group Virology Committee Resistance Working Group
A J Japour, D L Mayers, V A Johnson, et al.
Journal of Leukocyte Biology
|
September 14, 2000
Co-receptor usage was more predictive than NSI/SI phenotype for HIV replication in macrophages: is NSI/SI phenotyping sufficient?
J L Lathey, D Brambilla, M M Goodenow, et al.
AIDS (London, England)
|
August 16, 2001
A menstrual cycle pattern for cytokine levels exists in HIV-positive women: implication for HIV vaginal and plasma shedding
L Al-Harthi, A Kovacs, R W Coombs, et al.
The Journal of Infectious Diseases
|
October 13, 2001
Variation of human immunodeficiency virus type 1 viral RNA levels in the female genital tract: implications for applying measurements to individual women
R W Coombs, D J Wright, P S Reichelderfer, et al.
Journal of Clinical Microbiology
|
September 1, 1996
Evaluation of an infectivity standard for real-time quality control of human immunodeficiency virus type 1 quantitative micrococulture assays. Participating Laboratories of The AIDS Clinical Trials Group
W A Scott, D Brambilla, E Siwak, et al.
Page
of 3